191 related articles for article (PubMed ID: 25181622)
1. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
2. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
3. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
Haque N; Bilkis L; Haque N; Bari MS; Haque S
Mymensingh Med J; 2009 Jan; 18(1 Suppl):S40-44. PubMed ID: 19377430
[TBL] [Abstract][Full Text] [Related]
4. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
5. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study.
Hamm J; Russell Z; Botha T; Carlan SJ; Richichi K
Am J Obstet Gynecol; 2005 May; 192(5):1404-6. PubMed ID: 15902121
[TBL] [Abstract][Full Text] [Related]
6. [Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial].
Fekih M; Jnifene A; Fathallah K; Ben Regaya L; Memmi A; Bouguizene S; Chaieb A; Bibi M; Khairi H
J Gynecol Obstet Biol Reprod (Paris); 2009 Nov; 38(7):588-93. PubMed ID: 19833454
[TBL] [Abstract][Full Text] [Related]
7. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
[TBL] [Abstract][Full Text] [Related]
8. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
[TBL] [Abstract][Full Text] [Related]
9. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery.
Lapaire O; Schneider MC; Stotz M; Surbek DV; Holzgreve W; Hoesli IM
Int J Gynaecol Obstet; 2006 Oct; 95(1):2-7. PubMed ID: 16934269
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
[TBL] [Abstract][Full Text] [Related]
11. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor.
Bamigboye AA; Merrell DA; Hofmeyr GJ; Mitchell R
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):178-81. PubMed ID: 9512323
[TBL] [Abstract][Full Text] [Related]
13. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial.
Calişkan E; Meydanli MM; Dilbaz B; Aykan B; Sönmezer M; Haberal A
Am J Obstet Gynecol; 2002 Oct; 187(4):1038-45. PubMed ID: 12389002
[TBL] [Abstract][Full Text] [Related]
14. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section.
Eftekhari N; Doroodian M; Lashkarizadeh R
J Obstet Gynaecol; 2009 Oct; 29(7):633-6. PubMed ID: 19757270
[TBL] [Abstract][Full Text] [Related]
15. Misoprostol versus oxytocin for the reduction of postpartum blood loss.
Baskett TF; Persad VL; Clough HJ; Young DC
Int J Gynaecol Obstet; 2007 Apr; 97(1):2-5. PubMed ID: 17321529
[TBL] [Abstract][Full Text] [Related]
16. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor.
Ng PS; Lai CY; Sahota DS; Yuen PM
Gynecol Obstet Invest; 2007; 63(1):55-60. PubMed ID: 16940738
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
Singh G; Radhakrishnan G; Guleria K
Int J Gynaecol Obstet; 2009 Nov; 107(2):130-4. PubMed ID: 19628206
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
[TBL] [Abstract][Full Text] [Related]
19. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery.
Gerstenfeld TS; Wing DA
Am J Obstet Gynecol; 2001 Oct; 185(4):878-82. PubMed ID: 11641670
[TBL] [Abstract][Full Text] [Related]
20. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
